Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD): Current Perspectives
by
Waziri, Bala
, Naicker, Saraladevi
, Duarte, Raquel
in
Aluminum
/ Biological markers
/ Bone diseases
/ Calcification
/ Calcium phosphates
/ chronic kidney disease-mineral and bone disorder
/ Chronic kidney failure
/ Clinical trials
/ Drinking water
/ emerging trends
/ Endocrine system
/ Fibroblast growth factor 23
/ Fibroblast growth factors
/ Fibroblasts
/ Fractures
/ Growth factors
/ Hemodialysis
/ Hormones
/ Hypotheses
/ Kidney diseases
/ management
/ Metabolism
/ Minerals
/ Parathyroid
/ Parathyroid hormone
/ Parathyroid hormones
/ Pathogenesis
/ Phosphate binders
/ Phosphates
/ Review
/ updated pathogenesis
/ Vitamin D
2019
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD): Current Perspectives
by
Waziri, Bala
, Naicker, Saraladevi
, Duarte, Raquel
in
Aluminum
/ Biological markers
/ Bone diseases
/ Calcification
/ Calcium phosphates
/ chronic kidney disease-mineral and bone disorder
/ Chronic kidney failure
/ Clinical trials
/ Drinking water
/ emerging trends
/ Endocrine system
/ Fibroblast growth factor 23
/ Fibroblast growth factors
/ Fibroblasts
/ Fractures
/ Growth factors
/ Hemodialysis
/ Hormones
/ Hypotheses
/ Kidney diseases
/ management
/ Metabolism
/ Minerals
/ Parathyroid
/ Parathyroid hormone
/ Parathyroid hormones
/ Pathogenesis
/ Phosphate binders
/ Phosphates
/ Review
/ updated pathogenesis
/ Vitamin D
2019
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD): Current Perspectives
by
Waziri, Bala
, Naicker, Saraladevi
, Duarte, Raquel
in
Aluminum
/ Biological markers
/ Bone diseases
/ Calcification
/ Calcium phosphates
/ chronic kidney disease-mineral and bone disorder
/ Chronic kidney failure
/ Clinical trials
/ Drinking water
/ emerging trends
/ Endocrine system
/ Fibroblast growth factor 23
/ Fibroblast growth factors
/ Fibroblasts
/ Fractures
/ Growth factors
/ Hemodialysis
/ Hormones
/ Hypotheses
/ Kidney diseases
/ management
/ Metabolism
/ Minerals
/ Parathyroid
/ Parathyroid hormone
/ Parathyroid hormones
/ Pathogenesis
/ Phosphate binders
/ Phosphates
/ Review
/ updated pathogenesis
/ Vitamin D
2019
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD): Current Perspectives
Journal Article
Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD): Current Perspectives
2019
Request Book From Autostore
and Choose the Collection Method
Overview
Despite the availability of global and regional guidelines to curtail the adverse clinical outcomes associated with chronic kidney disease-mineral and bone disorder (CKD-MBD), most CKD patients are still affected by the consequences of abnormalities of CKD-MBD. This important clinical complication of CKD continues to be studied, in order to improve the understanding and management of CKD-MBD. Some notable discoveries include the role of fibroblast growth factor 23 (FGF23) in the pathogenesis of CKD-MBD, leading to a shift from the previous well-established classic trade-off hypothesis to the updated trade-off hypothesis. More recently, there has been a shift from the treatment of CKD-MBD based on a single level of biomarkers to serial measurements of calcium, phosphate and parathyroid hormone (PTH). Furthermore, some clinical trials have emerged after the 2009 Kidney Disease-Improving Global Outcomes (KDIGO) Guidelines, leading to the 2017 KDIGO updated recommendations. Hence, this review gives an overview of the rapidly evolving trends in CKD-MBD, linking the past and current concepts of CKD-MBD.
Publisher
Dove Medical Press Limited,Taylor & Francis Ltd,Dove Press,Dove,Dove Medical Press
Subject
This website uses cookies to ensure you get the best experience on our website.